Blau Farmacêutica S.A. (BVMF:BLAU3)
Brazil · Delayed Price · Currency is BRL 9.62
-0.18 (-1.84%)
At close: Mar 20, 2026
Blau Farmacêutica Revenue
In the year 2025, Blau Farmacêutica had annual revenue of 1.70B BRL, down -2.96%. Blau Farmacêutica had revenue of 389.36M in the quarter ending December 31, 2025, a decrease of -14.62%.
Revenue
1.70B
Revenue Growth
-2.96%
P/S Ratio
1.31
Revenue / Employee
895.99K
Employees
1,900
Market Cap
2.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.70B | -51.99M | -2.96% |
| Dec 31, 2024 | 1.75B | 381.74M | 27.81% |
| Dec 31, 2023 | 1.37B | -34.28M | -2.44% |
| Dec 31, 2022 | 1.41B | 40.50M | 2.96% |
| Dec 31, 2021 | 1.37B | 184.60M | 15.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 55.73B |
| Raia Drogasil | 44.25B |
| Empreendimentos Pague Menos | 14.91B |
| Diagnósticos da América | 12.57B |
| Fleury | 8.29B |
| Hypera | 7.70B |
| Oncoclínicas do Brasil Serviços Médicos | 5.94B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |